Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristics.

Fitzpatrick, Lorraine A; Bilezikian, John P; Wooddell, Margaret; Paul, Gitanjali; Kolatkar, Nikheel S; Nino, Antonio J; Miller, Colin G; Bogado, Cesar E; Arnaud, Claude D; Cobitz, Alexander R

Fitzpatrick, Lorraine A; Bilezikian, John P; Wooddell, Margaret; Paul, Gitanjali; Kolatkar, Nikheel S; Nino, Antonio J; Miller, Colin G; Bogado, Cesar E; Arnaud, Claude D; Cobitz, Alexander R.

Afiliação

Fitzpatrick LA; GlaxoSmithKline Research and Development, 709 Swedeland Road, King of Prussia, PA 19406USA.
Bilezikian JP; College of Physicians and Surgeons, Columbia University, New York, NY, USA. Department of Medicine, College of Physicians and Surgeons, Columbia University, 630 W. 168th Street, New York, NY 10032USA.
Wooddell M; GlaxoSmithKline Research and Development, 2301 Renaissance Boulevard, King of Prussia, PA 19406USA.
Paul G; GlaxoSmithKline Research and Development, 2301 Renaissance Boulevard, King of Prussia, PA 19406USA.
Kolatkar NS; GlaxoSmithKline Research and Development, 2301 Renaissance Boulevard, King of Prussia, PA 19406USA.
Nino AJ; GlaxoSmithKline Research and Development, 2301 Renaissance Boulevard, King of Prussia, PA 19406USA.
Miller CG; BioClinica Inc., 826 Newtown-Yardley Road, Newtown, PA 18940USA.
Bogado CE; Instituto de Investigaciones, Metabolicas, Libertad 836 C1012AAR Buenos AiresArgentina.
Arnaud CD; Imaging Therapeutics, 24301 Southland Drive, Suite 623, Hayward, CA 94545USA.
Cobitz AR; GlaxoSmithKline Research and Development, 2301 Renaissance Boulevard, King of Prussia, PA 19406USA.